You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

NAPHAZOLINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for NAPHAZOLINE HYDROCHLORIDE
US Patents:0
Tradenames:10
Applicants:8
NDAs:12
Drug Master File Entries: 6
Raw Ingredient (Bulk) Api Vendors: 91
Clinical Trials: 5
Patent Applications: 3,927
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in NAPHAZOLINE HYDROCHLORIDE?NAPHAZOLINE HYDROCHLORIDE excipients list
DailyMed Link:NAPHAZOLINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for NAPHAZOLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Sophia S.A de C.V.Phase 1
SanofiPhase 1
EMSPhase 3

See all NAPHAZOLINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for NAPHAZOLINE HYDROCHLORIDE

US Patents and Regulatory Information for NAPHAZOLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb NAFAZAIR naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 040073-001 May 25, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb OPCON-A naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 020065-001 Jun 8, 1994 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis VASOCON naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 080235-002 Mar 24, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alcon NAPHCON FORTE naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 080229-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb OPCON naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 087506-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allergan ALBALON naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 080248-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.